MTOR and pulmonary arterial hypertension: We hypothesize that VPS34 and its increased activation are responsible for the hyper-proliferation in the diseased PAVSMC from patients with PAH; however, the mechanisms by which the VPS34/mTOR axis is activated, especially the regulation of TSC2 by VPS34, in PAVSMC is yet to be unveiled.